Back
Incyte Stock Predictions
Sponsored
INCY
Sponsored
Write This Down: Tuesday at 2 p.m. ET!
Don't Miss Our LIVE Trade
Buy
70
INCY
Incyte
Last Price:
83.41
Seasonality Move:
35.45%
7 Day Trial
ALL ACCESS PASS
$
7
U.S. Government Report Alert Tuesday
Discover the Secret LoopholeIncyte Stock Forecast
- Over the next 52 weeks, Incyte has on average historically risen by 32.4% based on the past 30 years of stock performance.
- Incyte has risen higher in 17 of those 30 years over the subsequent 52-week period, corresponding to a historical accuracy of 56.67%
-
Is Incyte Stock Undervalued?
The current Incyte [INCY] share price is $83.38. The Score for INCY is 70, which is 40% above its historic median score of 50, and infers lower risk than normal. - INCY is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
Will Incyte Stock Go Up Next Year?
- Over the next 52 weeks, Incyte has on average historically risen by 32.4% based on the past 30 years of stock performance.
Incyte Stock Rating
Buy
70
Incyte (INCY)
is a Buy
Is Incyte overpriced?
- Incyte has risen higher in 17 of those 30 years over the subsequent 52-week period, corresponding to a historical accuracy of 56.67%
Incyte Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
incyte.com
52-Week Data
52-Week High:
83.95
52-Week Low:
50.35
Prediction Charts
Market Cap:
16.06B
Price in USD:
83.38
Volume:
2.95M
Beta:
1.41
Technical Analysis
SMA50:
67.47
SMA100:
65.32
SMA200:
61.26
52-Wk Change:
54.24%
Stock Predictions
-
Is Incyte stock public?
Yes, Incyte is a publicly traded company. -
What is the Incyte stock quote today?
The Incyte stock price is 83.38 USD today. -
How to buy Incyte stock online?
You can buy Incyte shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
Oct-22 | 65.03 | 65.59 | 65.78 | 64.60 |
Oct-23 | 65.49 | 65.17 | 66.10 | 64.76 |
Oct-24 | 65.24 | 65.24 | 65.91 | 65.08 |
Oct-25 | 65.32 | 65.07 | 65.74 | 64.99 |
Oct-28 | 65.49 | 65.69 | 65.88 | 64.86 |
Oct-29 | 67.53 | 73.60 | 74.07 | 66.95 |
Oct-30 | 73.60 | 73.94 | 74.60 | 72.50 |
Oct-31 | 73.91 | 74.12 | 74.68 | 73.28 |
Nov-1 | 74.12 | 76.13 | 76.33 | 73.91 |
Nov-4 | 75.07 | 75.75 | 76.57 | 75.07 |
Nov-5 | 75.77 | 77.28 | 77.37 | 75.34 |
Nov-6 | 78.45 | 80.95 | 82.19 | 78.21 |
Nov-7 | 81.00 | 82.34 | 82.97 | 79.53 |
Nov-8 | 82.59 | 83.38 | 83.95 | 82.15 |
Incyte Earnings
Incyte Earnings Report: Per Share Incyte Earnings Q1 Q2 Q3 and Q4 last year and next year.
Incyte Forecast Revenue Growth
Incyte Stock Analysis: Historical quarterly revenues per share for Incyte and historical quarterly revenue growth:
- Analysts estimate an earnings decrease this quarter of $0.47 per share, a decrease next quarter of $0.00 per share, a decrease this year of $2.29 per share, and an increase next year of $4.72 per share.
* Incyte stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.